Association Between HRV and Postoperative Mortality in Hip Fracture Patients (NCT03426501) | Clinical Trial Compass
CompletedNot Applicable
Association Between HRV and Postoperative Mortality in Hip Fracture Patients
165 participantsStarted 2008-01-15
Plain-language summary
165 patients admitted to two hospitals were included and short-time HRV measurements were obtained. Mortality data were gathered from the Norwegian central address register. Patients, close relatives of patients and in some cases their general physicians or nursery home physicians were interviewed six months postoperatively regarding the incidence of pneumonia, cardiac events or stroke.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Hip fracture with indication of operative treatment.
* Preoperative ECG
* Preoperative CKMB and Troponin I
Exclusion Criteria:
* Cardiocirculatoric unstable patient Atrial fibrillation
* Agitated patient were it is unpossible to obtain a 10 minute ECG
* Other operation in the last month
* Cancer patients in an advanced stadium
* Preterminal or terminal patients
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This study tracked heart rate variability to predict who might not survive six months after hip fracture surgery — can you explain what heart rate variability is, and whether measuring mine before or after surgery could give us useful information about my own risk?
2Since this trial has already been completed and was measuring survival outcomes at six months, has the data been published yet, and what did it find about which patients were at higher risk of not making it through that period?
3I know this was an observational study, not a treatment trial — so does the research change anything about how you would actually manage my care, or is it more about identifying warning signs to watch for?
4Hip fracture surgery already carries serious risks for older patients — based on what this study was looking at, are there specific factors in my health profile, like heart or nervous system function, that you think put me in a higher-risk group we should plan around?
5Are there other monitoring tools or interventions being studied right now that go beyond just predicting risk, and would any of those be worth discussing as part of my overall care plan?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Number of Surviving patients six months after hip operation